help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MOLINARI, J. F.
Right arrow Articles by AHMED, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MOLINARI, J. F.
Right arrow Articles by AHMED, T.

Am. J. Respir. Crit. Care Med., Volume 157, Number 3, March 1998, 887-893

Inhibition of Antigen-induced Airway Hyperresponsiveness by Ultralow Molecular-weight Heparin

JUSSARA F. MOLINARI, CARLOS CAMPO, SHAHIDA SHAKIR, and TAHIR AHMED

Division of Pulmonary Diseases, University of Miami School of Medicine, Mount Sinai Medical Center, Miami Beach, Florida

Unfractionated heparin (UF-heparin) has been shown to prevent antigen-induced airway hyperresponsiveness (AHR), but it is ineffective when administered after the antigen challenge. We hypothesized that the failure of UF-heparin to modify postantigen AHR might depend on molecular weight. We therefore studied the effects of UF-heparin and three low-molecular-weight heparin fractions (medium-molecular-weight heparin [MMWH]; low-molecular-weight heparin [LMWH]; and ultralow-molecular-weight heparin [ULMWH]) on antigen-induced AHR and histamine release in bronchoalveolar lavage fluid (BALF). Specific lung resistance (SRL) was measured in 20 allergic sheep before, immediately after, and up to 2 h after challenge with Ascaris suum antigen. Airway responsiveness was expressed as the cumulative provocative dose of carbachol, in breath units, that increased SRL by 400% (PD400). PD400 was determined before and 2 h after antigen, both without and after treatment with aerosolized UF-heparin (1,000 U/kg) and various heparin fractions (0.04 mg/kg to 5 mg/kg) administered after the antigen challenge. Inhaled UF-heparin (n = 4), MMWH (n = 4), and LMWH (n = 6) failed to modify postantigen AHR when administered after the challenge. Only ULMWH (n = 6) inhibited postantigen AHR in a dose-dependent manner (percent protection ranged from 31% to 139%). In eight additional sheep, histamine in BALF was measured with a radioimmunoassay (RIA) before and after the segmental antigen challenge, without and after pretreatment with inhaled UF-heparin, LMWH, or ULMWH. Inhaled UF-heparin and LMWH inhibited antigen-induced histamine release as measured in BALF by 81% and 75%, respectively; whereas ULMWH was ineffective in this respect. We conclude that: (1) modification of antigen-induced AHR by fractionated heparins is molecular-weight dependent; and (2) only ULMWH attenuates AHR when administered after antigen challenge, via an unknown mast-cell-independent action.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
H. Maarsingh, B. E. Bossenga, I. S. T. Bos, H. H. Volders, J. Zaagsma, and H. Meurs
L-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction
Eur. Respir. J., July 1, 2009; 34(1): 191 - 199.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. Ahmed, J. Ungo, M. Zhou, and C. Campo
Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides
J Appl Physiol, May 1, 2000; 88(5): 1721 - 1729.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. AHMED, B. J. GONZALEZ, and I. DANTA
Prevention of Exercise-induced Bronchoconstriction by Inhaled Low-molecular-weight Heparin
Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 576 - 581.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
C. Campo, J. F. Molinari, J. Ungo, and T. Ahmed
Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses
J Appl Physiol, February 1, 1999; 86(2): 549 - 557.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society 		  Tobacco